Fig. 1From: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome dataForest plots showing the effects of GLP-1- and non-GLP-1-based therapies on a MACE, b myocardial infarctionBack to article page